Antibodies to human I-branching beta-1,6-N-acetylglucosaminyltra

Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

5303891, 5303879, C07K 1600, C12P 2108

Patent

active

057314209

ABSTRACT:
The present invention provides an isolated nucleic acid molecule encoding both a soluble and membrane-bound human .beta.-1,6-N-acetylglucosaminyltransferase, the I-branching enzyme (IGnT). The invention also provides vectors containing the isolated nucleic acid molecule encoding human IGnT as well as recombinant host cells transformed with the vectors. The invention further provides a method of preparing a membrane-bound form of human IGnT and methods of preparing and purifying soluble human IGnT and active fragments of either form. Also provided are antisense oligonucleotides complementary to a nucleic acid molecule encoding a human IGnT or an active fragment thereof, antibodies directed to the human IGnT, pharmaceutical compositions related to the human IGnT and transgenic nonhuman mammals expressing DNA encoding normal or mutant human IGnT. Also provided are methods for regulating the expression of human IGnT and methods for modifying a biological function mediated by the regulatory activity of human IGnT. Methods of detecting the presence of linear polylactosaminoglycans expressing i antigenic determinants on a cell surface also are provided.

REFERENCES:
patent: 5032519 (1991-07-01), Paulson et al.
patent: 5324663 (1994-06-01), Lowe
patent: 5360733 (1994-11-01), Fukuda
Schachater, Harry "Condensation of Research" Chemtracts-Biochemistry and Molecular Biology 4:164-167 (1993).
Joziasse, D. H. "Mammalian Glycosyltransferases: Genomic Organization and Protein Structure." Glycobiol. 2:271-277 (1992).
Paulson, J.C. and Colley, K.J. "Glycosyltransferases, Structure, Localization and Control of Cell Type-Specific Glycosylation." J. Biol. Chem. 264:17615-17618 (1989).
Schachter, H. "Enzymes Associated With Glycosylation." Curr. Opinion Struct. Biol. 1:755-765 (1991).
Smith, D.F. et al., "Transfer and Expression of a Murine IDP-Gal:.beta.-D-Gal-.alpha.1,3-galactosylatransferase in Chinese Hamster Ovary Cells." J. Biol. Chem. 265:6225-6235 (1990).
Gu, Jianguo et al., "Deficiency of .beta.1-6 N-Acetylglucosaminyltransferase Involved in the Biosynthesis of Blood Group I Antigen in the Liver of LEC Rats." Jpn. J. Cancer Res. 83:878-884 (1992).
Bierhuizen, Marti F.A. and Fukuda, Minoru. "Expression Cloning of a cDNA Encoding UDP-GlcNAc:Gal.beta.1-3-GalNAc-R (GlcNAc to GalNAc) .beta.1-6GlcNAc Transferase by Gene Transfer Into CHO Cells Expressing Polyoma Large Tumor Antigen." Proc. Natl. Acad. Sci. USA 89:9326-9330 (1992).
Piller, Friedrich et al., "Biosynthesis of Blood Group I Antigens." J. Biol. Chem. 259:13385-13390 (1984).
Zielenski, Julian and Koscielak, Jerzy, "Sera of i Subjects Have the (.beta.1.fwdarw.3)! Gal . . . Structure."FEBS. 163:114-118 (1983).
Bierhuizen, Marti F.A. et al. "Expression of the Developmental I Antigen by a Cloned Human cDNA Encoding a Member of a .beta.-1, 6-N-Acetylglucosaminyltransferase Gene Family."Genes and Development. 7:468-478 (1993).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Antibodies to human I-branching beta-1,6-N-acetylglucosaminyltra does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibodies to human I-branching beta-1,6-N-acetylglucosaminyltra, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to human I-branching beta-1,6-N-acetylglucosaminyltra will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2289756

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.